Showing results (171-180 of 332) with videos related to
Sort By:
Pageof 34
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2021
Post-vaccine COVID-19 in patients with multiple sclerosis or neuromyelitis opticaEdouard Januel, Jérôme De Seze, Patrick Vermersch, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 26, 2021
Memory B Cells Predict Relapse in Rituximab-Treated Myasthenia GravisCaroline Ruetsch-Chelli, Saskia Bresch, Barbara Seitz-Polski, et al.Neurology and Therapy|April 10, 2025
Impact of Natalizumab on Productivity and Ability to Work in Patients with Multiple Sclerosis in France: The TITAN StudyPatrick Vermersch, Arnaud Kwiatkowski, Jérôme de Sèze, et al.Neurology and Therapy|April 26, 2024
Dental Adverse Effects of Anti-CD20 TherapiesHélène Bartak, Tasnim Fareh, Nouha Ben Othman, et al.Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 2, 2020
Outcome of patients with sarcoidosis refractory to TNF antagonists: a case seriesClémence Thery-Casari, Yvan Jamilloux, Diane Bouvry, et al.Brain : a Journal of Neurology|June 17, 2010
Geographic variations of multiple sclerosis in FranceAgnes Fromont, Christine Binquet, Erik A Sauleau, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2026
A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosisNail Benallegue, Fabien Rollot, Pietro Iaffaldano, et al.Plos One|September 21, 2017
Isolated positive anti-SS-B autoantibodies are not related to clinical features of systemic autoimmune diseases: Results from a routine population surveySabine Jardel, Nicole Fabien, Arnaud Hot, et al.European Neurology|August 22, 2012
Clinical and radiological characteristics in multiple sclerosis patients with large cavitary lesionsDimitri Renard, Bruno Brochet, Sandra Vukusic, et al.Frontiers in Neurology|April 5, 2021
Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data NetworkJan Hillert, Melinda Magyari, Per Soelberg Sørensen, et al.Pageof 34